Data / Form D filings / Magna Pharmaceuticals, Inc.
Magna Pharmaceuticals, Inc.: Form D filings
Magna Pharmaceuticals, Inc., a pharmaceuticals company in Louisville, KY, filed 2 Form D notices with the SEC in 2014. The latest, on May 21, 2014, reports $499,016 sold of a $3.8 million offering to 1 investor.
Find out what Magna Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10801 ELECTRON DRIVE, SUITE 100, Louisville, KY, 40299
- Phone
- (502) 254-5552
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Kentucky
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 505, Rule 506(b)
- SEC identifier (CIK)
- 1596152
The full lists. Form D filings in Kentucky: 216 rows, $10.80, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 21, 2014 | Amendment | $3,752,000 | $499,016 | $3,252,984 | 1 | Dec 30, 2013 | sec.gov |
| Jan 10, 2014 | New notice | $3,500,616 | $1,005,536 | $2,495,080 | 1 | Dec 30, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Warren Paul Lesser | Executive Officer, Director, Promoter |
Every Form D from the week of May 19, 2014 · All recent filings in Kentucky · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Magna Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.